Clinical, pathological and molecular factors predicting axillary node involvement in primary breast cancer in pakistani women

Journal of the Pakistan Medical Association

Volumn 52, Issue 5, 2002, Pages 192-195

  Siddiqui, T ^a   Khan, S ^a   Kayani, N ^a   Pervez, S ^a   Salam, A ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE;

ARTICLE; AXILLA; BREAST TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; PAKISTAN; PATHOLOGY;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; PAKISTAN; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0036560680     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Clark GM, Prognostic and predictive factors, in: Diseases of the breast. Harris JR, Lippman ME, Morrow M, et al. (eds). Philadelphia, Lippincott-Raven, 2000, pp. 489-514.
2. Patrick LF, Page DL, Weaver D, et al. Prognostic factors in breast cancer (College of American Pathologists Consensus Statement 1999). Arch. Pathol. Lab. Med; 2000; 124:966 - 75.
3. OsbomeKC, Clark GM, Ravdin PM. Adjuvant systemic therapy of breast cancer, in: diseases of the breast, in:Harris JR, Lippman ME, Morrow M, et al. (eds.). Philadelphia,Lippincott - Raven, 2000, pp. 599- 632.
4. Shriver MD. Ethnic variation as a key to the biology of human disease (ed.). Ann. Int. Med., 1997; 5: 401 - 3.
5. EdwardsMJ, Game JW, Vaughan WP, et al. Infiltrating ductal carcinoma of the breast - the survival impact of race. J. Clin. Oncol., 1998; 16: 2693 - 99.
6. DeMichele A, Weber B. Recent advances in breast cancer biology. Current Opin. Oncol., 1997; 9: 499 - 504.
7. Muss HB, Thor AD, Berry DA, et al. erb - B 2 expression and response to adjuvant therapy in women with node positive early breast cancer. N. Eng. J. Med., 1994; 330: 1260 - 66.
8. Basegla J. Clinical trials of herceptin (trastuzumab). EurJ. Canc., 2001; 37 (suppl.). 1S18-24.
9. Krag D.Weaver D, Ashikaga T,et al. The sentinal node in breast cancer. N. Eng. J. Med.,1998;14 :941-46.
10. Fisher B, Brown A, Marmounas E, et al. Effect of preoperative chemotherapy on local regional disease in women with operable breast cancer. Findings from the national surgical adjuvant breast and bowel project, B18. J. Clin. Oncol., 1997; 15: 2483 - 93.
11. Barth A, Craig PH, Silverstein MJ, et al. Predictors of axillary lymph node metastasis in patients with T1 breast carcinoma. Cancer, 1997; 79: 1918 - 22.
12. Cady B .Use of primary Breast cancer characteristics to predict lymph node metastasis. Cancer, 1997; 79: 1856 - 61.
13. Maibenko DC, Linda K, Weiss LK, et al. Axillary lymph node metastasis associated with small invasive breast carcinomas. Cancer, 1999; 85: 1530 - 35.
14. O'Reilly SM, Campeljohn RS, Barnes DM, et al. Node negative breast cancer, prognostic subgroups defined by tumor size and flow cytomety. J. Clin. Oncol., 1990; 8: 2040 - 46.
15. Ravdin PM, De Laureates M, Vendely T, et al. Prediction of axillary nodal status in breast cancer patients by the use of prognostic indicators. J. Nat. Can. Inst., 1994; 86:1971-78.
16. Shetty MR, Rieman HM. Tumor size and axillary metastasis, a correlative occurrence in 1244 cases of breast cancer between 1980 and 1995. Eur. J. Surg. Oncol., 1997 ;23: 139-41.
17. Barth A, Silverstein MJ, Craig PH, et al. Predicting axillary node metastasis: 918 patients with T1 breast carcinoma. Proc. Am. Soc.Clin. Oncol., 1996; 15: A 48.
18. Nathanson SD, Zarbo RJ, Wachna DL, et al. Micro vessels that predict axillary node metastasis in patients with breast cancer. Arch. Surg., 2000; 135:586-93.